From ebf03868e7679ced14f53ccbb2c06806cebe18aa Mon Sep 17 00:00:00 2001 From: karinashin Date: Mon, 18 Apr 2022 23:09:38 -0500 Subject: [PATCH] parsing larger sets --- .../2018_03_112b52537b67659ad3609a234388c50a/news_0026371.json | 1 + 1 file changed, 1 insertion(+) create mode 100644 size_6000/2018_03_112b52537b67659ad3609a234388c50a/news_0026371.json diff --git a/size_6000/2018_03_112b52537b67659ad3609a234388c50a/news_0026371.json b/size_6000/2018_03_112b52537b67659ad3609a234388c50a/news_0026371.json new file mode 100644 index 0000000..4e51f0c --- /dev/null +++ b/size_6000/2018_03_112b52537b67659ad3609a234388c50a/news_0026371.json @@ -0,0 +1 @@ +{"organizations": [], "uuid": "845a375bb6937299507e0452ca0756ac9e0a08ed", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180115.html", "section_title": "Archive News & Video for Monday, 15 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-dermapharm-holding-plans-ipo-on-fr/brief-dermapharm-holding-plans-ipo-on-frankfurt-stock-exchange-idUSFWN1PA00W", "country": "US", "domain_rank": 408, "title": "BRIEF-Dermapharm Holding Plans IPO On Frankfurt Stock Exchange", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-15T15:06:00.000+02:00", "replies_count": 0, "uuid": "845a375bb6937299507e0452ca0756ac9e0a08ed"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-dermapharm-holding-plans-ipo-on-fr/brief-dermapharm-holding-plans-ipo-on-frankfurt-stock-exchange-idUSFWN1PA00W", "ord_in_thread": 0, "title": "BRIEF-Dermapharm Holding Plans IPO On Frankfurt Stock Exchange", "locations": [], "entities": {"persons": [], "locations": [{"name": "frankfurt", "sentiment": "none"}], "organizations": [{"name": "frankfurt stock exchange", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 15 (Reuters) - Dermapharm Holding SE:\n* PLANS INITIAL PUBLIC OFFERING ON FRANKFURT STOCK EXCHANGE\n* DERMAPHARM HOLDING - PLANNED SECONDARY OFFERING OF SHARES SHOULD ALLOW FOR A FREE FLOAT OF APPROX. 25%\n* DERMAPHARM HOLDING - PLANS A CAPITAL INCREASE WITH GROSS PROCEEDS OF APPROX. EUR 100 MILLION Source text for Eikon: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-15T15:06:00.000+02:00", "crawled": "2018-01-16T13:12:13.028+02:00", "highlightTitle": ""} \ No newline at end of file